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Background
Annually, 482,300 patients are diagnosed
with esophageal cancer worldwide, and
406,800 patients die of this disease [1].
Esophagolymphadenectomy is the cor-
nerstone of multimodality treatment for
locally advanced esophageal cancer [2,
3]. The preferred curative treatment
for esophageal cancer is transthoracic
esophagectomy with a two-ﬁeld lymph
node dissection and gastric conduit re-
construction [4]. This procedure allows
for enbloc resectionof the esophagus and
extensive mediastinal lymphadenectomy
[5].
Minimally invasive surgery was intro-
ducedtoreducesurgical traumaandpost-
operative morbidity. Minimally invasive
esophagectomy (MIE) has several advan-
tages over open esophagectomy, such as
diminished blood loss, reduced morbid-
ity, and shorter hospital stay [6, 7]. How-
ever, conventional thoracolaparoscopic
techniques are limited by a two-dimen-
sional view, a disturbed eye–hand co-
ordination, and a reduced freedom of
movement. These technical limitations
may compromise the feasibility of MIE
and its worldwide adaptation [8–10].
In 2003, the robot-assisted thoraco-
laparoscopic approach was developed at
the University Medical Center Utrecht
(UMC Utrecht) in The Netherlands
The German version of this article can be found
underdoi: 10.1007/s00104-016-0239-5.
[10]. Robot-assisted minimally invasive
esophagectomy (RAMIE) reduces the
limitations of thoracoscopic esophagec-
tomy by oﬀering a stable three-dimen-
sional (3D) view, 10-times-enlarged
image, restored eye–hand axis, and ex-
cellent dexterity with the endowristed
instruments. In this article we present
our technique, give suggestions for suc-
cessful implementation, discuss recent
developments, and look to the future
directions of RAMIE.
Fig. 18 Operating room set-up. (© 2014 Intuitive Surgical Inc., usedwith permission)
RAMIE at UMC Utrecht
Preparation
General and thoracic epidural anesthet-
ics are combined to ensure suﬃcient in-
traoperative and postoperative analgesia.
Recentlywe startedusing single-dose and
bilateral paravertebral block combined
with sufentanil in the context of our
enhanced recovery after esophagectomy
program. This may provide similar post-
operative analgesia and allow for early
discharge avoiding the disadvantages of
epidural anesthesia such as catheter mal-
position and hypotension [11]. The pa-
tient is intubated with a left-side double-
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Fig. 28 Trocarplacement in the thoracicphase.Roboticarms1 (yellow)and
2 (green), camera (blue), and two assisting ports (white).MAL (midaxillary
line) (©2014 Intuitive Surgical Inc., usedwith permission)
Fig. 38 Clipping anddissection of the azygos vein. (From [30])
Fig. 48 Trocar placement in the abdominal
phase. (From [8], by kind permission of JohnWi-
ley and Sons)
lumen tube and is positioned in the left
lateraldecubitusposition, tilted45° to the
prone position. The robotic system (da
Vinci Si System, Intuitive Surgical Inc.,
Sunnyvale, Calif.) is positioned on the
dorsocranial side of the patient (. Fig. 1).
Three ports are placed for the robotic sys-
tem as well as two ports for the assisting
surgeon (. Fig. 2), whereafter the right
lung is desuﬄated. Through one of the
assistant ports, CO2 at 6 mmHg is insuf-
ﬂated tokeep the lungoutof the operative
ﬁeld.
Surgical procedure
The right pulmonary ligament is divided
and the parietal pleura is dissected at the
anterior side of the esophagus from the
diaphragm up to the level of the azy-
gos arch. The azygos arch is ligated with
robotic Hem-o-lok clips (Teleﬂex Med-
ical, Durham, N.C.) and divided. These
clips are endowristed facilitating precise
positioning (. Fig. 3). To establish dis-
section of the right paratracheal lymph
nodes, dissection of the parietal pleura
is continued above the azygos arch. The
right vagal nerve is dissected below the
level of the carina to preserve its pul-
monary branches [12, 13]. Dissection of
the parietal pleura is continued from cra-
nially to caudally along the azygos vein at
the posterior side of the esophagus. Para-
tracheally left, the left recurrent nerve
is identiﬁed and carefully protected. At
the level of the diaphragm, the thoracic
duct is clipped with the robotic Hem-
o-lok clips to prevent leakage. At this
level, a Penrose drain is placed around
the esophagus to facilitate traction and
esophageal mobilization. The esopha-
gus is then resected from the diaphragm
up to the thoracic inlet en bloc with
the surrounding mediastinal and sub-
carinal lymph nodes and the thoracic
duct. The aortoesophageal arteries are
identiﬁed and clipped.
The patient is put in supine position
for the abdominal phase. After intro-
duction of the ﬁve trocars (. Fig. 4),
the hepatogastric ligament is opened
and transection of the lesser omentum
is continued until the left crus of the
diaphragm. Hereafter, the greater gastric
curvature is dissected using a harmonic
ace (Ethicon, Cincinnati, Ohio). Ab-
dominal lymphadenectomy is performed
including lymph nodes surrounding the
celiac trunk, along the left gastric and
splenic arteries and the lesser omental
lymph nodes. The left gastric artery
is ligated with Hem-o-lok and tran-
sected at its origin. Through a left-
sided vertical incision along the ster-
nocleidomastoid muscle, the cervical
phase of the esophagectomy is initiated
to facilitate mobilization of the cervical
esophagus. No formal cervical lymph
node dissection is carried out. The cervi-
cal esophagus is transected and a cord is
attached to the specimen. The dissected
esophagus with the surrounding lymph
nodes en bloc are pulled down through
the mediastinum under laparoscopic
view. Hereafter, the left para-umbili-
cal trocar port is widened to a 5–7-
cm transverse incision. The resection
specimen is removed through this inci-
sion with a wound drape (3M, St. Paul,
Minn.) to create the gastric conduit ex-
tracorporeally. A linear stapler (GIATM
80, 3.8 mm; Medtronic, Minneapolis,
Minn.) is used to create a 4-cm-wide
gastric conduit, which is routinely over-
sewn with a 3/0 polydioxanone single-
layer running suture. The gastric conduit
is pulled up through the mediastinum
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along the original anatomic tract of the
esophagus with the aid of a plastic tube
(laparoscopic camera bag). A cervical
hand-sewn end-to-side anastomosis is
created between the gastric tube and
the cervical esophagus using a 3/0 poly-
dioxanone single-layer running suture.
A jejunostomy feeding tube is placed in
the second loop after the ligament of
Treitz for postoperative feeding. The ab-
domen is closed in layerswith a PDS loop
for the fascia and skin intracutaneously
with Monocryl.
Pushing the limits of
esophagectomy with RAMIE
Since the introduction of RAMIE, we
havegainedconsiderableexperiencewith
the use of the da Vinci robot in over
300 cases. After a learning curve of 120
cases, a plateauwas reachedwith a steady
level of performance. Utilizing the full
capabilities of the da Vinci robot, we are
currently investigating new indications
in patients who were deemed inoperable
with conventional surgery.
Until recently, patients with cT4b
tumors were considered inoperable
and guidelines recommend deﬁnitive
chemoradiotherapy as the treatment
of choice [14]. However, cT4 status
is a negative predictor of locoregional
control [15]. Deﬁnitive chemoradio-
therapy is associated with a high rate of
esophageal stenosis and perforation, the
latter occurring in 25% of patients, and
most often these perforations are lethal.
Furthermore, functional results are poor
and there is frequently recurrence in up
to 41% of cases [15, 16]. Therefore, we
started salvage surgery with RAMIE in
patients with cT4b esophageal tumors
after long-course chemoradiotherapy.
The patients are restaged with positron
emissiontomography–computedtomog-
raphy and endobronchial ultrasound to
determine the actual situation, and they
are selected for salvage surgery if tracheal
ingrowth has been reduced (. Fig. 5).
The enlarged 3D image allows for very
precise dissection of the irradiated tu-
mor tissue from the trachea, bronchi,
and aorta. The level of precision makes
dissection in downstaged T4b tumors
feasible. So far, we have treated ten pa-
tients using this strategy, leading to
radical resections in 90% of cases (un-
published data). We are awaiting the
long-term oncologic and functional re-
sults with this approach before it can be
recommended for all patients.
Moreover, the upper mediastinum
and thoracic aperture can be reached
with an excellent 3D view and magni-
ﬁed observation of the operative ﬁeld
(. Fig. 6; [17]). In this way, we were able
to achieve an R0 resection in 28 out of 29
patients (97%) with upper esophageal
tumors and paratracheal lymph node
involvement (unpublished data).
Future directions include the use of
the robotic platform for image-guided
surgery and ﬂuorescence detection of
lymph nodes and tumor margins. The
integration of optical imaging modali-
ties that speciﬁcally visualize the areas of
interest may reduce complications and
improve the surgical accuracy of lymph
node dissection [18].
Another application of intravascular
ﬂuorescence dye imaging is the intraop-
erative assessment of the vascularization
of the gastric conduit. This may guide
one to the optimal site of the anastomo-
sis and thereby contribute to reducing
anastomotic leakage [19].
Surgical training program
We have developed a structured train-
ing program that enables esophageal
surgeons to be guided through the
learning curve in 20 cases. The proc-
tored surgeons should have basic min-
imally invasive skills and knowledge
of esophageal surgery. The program
starts with three case observations in
a RAMIE expert center, followed by
a basic robotic course and a cadaveric
laboratory course. Thereafter, the proc-
tor supervises the surgeon for the ﬁrst
three to ten cases and reviews his skills
after the ﬁrst 20.
Optimal performance during techni-
cally complex procedures requires a ded-
icated team [20]. Therefore, at least two
motivated surgeons, a dedicated anes-
thetist, and a scrub nurse should be in-
volved in the program. A suﬃcient case
load (>20/year) and guaranteed access to
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Esophagolymphadenectomy is the corner-
stone ofmultimodality treatment for resecta-
ble esophageal cancer. The preferred surgical
approach is transthoracic, with a two-
ﬁeld lymph node dissection and gastric
conduit reconstruction. A minimally invasive
approach has been shown to reduce post-
operative complications and increase quality
of life. Robot-assistedminimally invasive eso-
phagectomy (RAMIE) was developed to faci-
litate this complex thoracoscopic procedure.
RAMIE has been shown to be safe with good
oncologic results and reduced morbidity.
The use of RAMIE opens new indications for
curative surgery in patientswith T4b tumors,
high mediastinal tumors, and lymph node
metastases after neoadjuvant treatment.
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Die Ösophagolymphadenektomie ist der
Eckpfeiler der multimodalen Behandlung
des resektablen Ösophaguskarzinoms. Der
chirurgische Zugang erfolgt bevorzugt
transthorakal, mit 2-Feld-Lymphadenek-
tomie und Rekonstruktion durch Magen-
hochzug. Für einen minimal-invasiven
Ansatz wurde gezeigt, dass er die postope-
rativen Komplikationen reduziert und die
Lebensqualität erhöht. Die roboterassistierte
minimal-invasiveÖsophagektomie (RAMIE)
wurde mit dem Ziel entwickelt, dieses
komplexe thorakoskopische Verfahren zu er-
leichtern. Die Sicherheit der RAMIE ist belegt,
die onkologischen Ergebnisse sind gut, die
Morbidität wird verringert. Die Anwendung
eröﬀnet neue Indikationen für die kurative
chirurgische Behandlung von Patienten
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Fig. 58 T4b esophageal tumors, tracheal involvement.ES esophagus,
CA carina, LB left bronchus, RB right bronchus TR trachea, RL right lung
Fig. 68 Uppermediastinum. ES esophagus,VN vagal nerve, TR trachea,
RL right lung, SC subclavian artery
arobotic systemareofcrucial importance
[21, 22].
In urology, proctoring has proven to
be an essential mechanism for the suc-
cessful implementation of robot-assisted
radical prostatectomy, and this approach
is comparable in RAMIE [23].
Discussion
RAMIE oﬀers a 3D, magniﬁed surgical
viewcombinedwithahighdegreeof free-
domof the articulating instruments. This
facilitatesmeticulous dissection from the
diaphragm to the thoracic inlet. Espe-
cially for the thoracic phase, where the
esophagus is surrounded by delicate vital
structuressuchas the trachea, pulmonary
veins, aorta, and recurrent nerves, these
features are of great value. Moreover,
these features allowtheexplorationof sal-
vage surgery in patients with previously
inoperable T4b and upper mediastinal
tumors.
Robotic assistance may also facilitate
the use of an intrathoracic anastomo-
sis [24]. Until recently, we performed
a three-stage esophagectomy (McKeown
procedure) with a hand-sewn esopha-
gogastric anastomosis in the left side of
the neck as stated previously. However,
the incidenceofanastomotic leakageafter
cervical esophagogastrostomy remains
relatively high (10–30 %) and intratho-
racic manifestation occurs in more than
half of patients with cervical anasto-
motic leakage [25, 26]. The incidence of
leakage from intrathoracic anastomosis
is reported to be lower [27]. Therefore,
we started performing a two-stage (Ivor
Lewis) procedure with a robotic hand-
sewn intrathoracic anastomosis for dis-
tal esophageal tumors. Constructing an
intrathoracic anastomosis during con-
ventional thoracoscopy is technically
challenging. By working in the upper
thoracic aperture, the instruments have
to reach deep into the thorax, impos-
ing problems in manipulation through
the fulcrum eﬀect at the ribs [28]. The
robot nulliﬁes these problems owing to
the endo-wristed intracorporeal instru-
ments, tremor ﬁltering, and its 3D view
of the surgical ﬁeld. Therefore, in our
opinion the robot contributes to a high-
quality intrathoracic anastomosis. In
our initial experience, we have found the
hand-sewn robotic technique to be very
controlled and reliable. Larger numbers
of patients have to be treated with this
technique before the success rates and
long-term results can be reported.
So far, we have chosen to perform
the abdominal aspect of our procedure
via a laparoscopic approach, since the da
Vinci Si Surgical System (Intuitive Sur-
gical Inc.) was not constructed to facili-
tate multiquadrant surgery. The new da
Vinci Xi Surgical System (Intuitive Surgi-
cal Inc.) has its four arms mounted on an
overhead boom enabling multiquadrant
surgery without the need to redock the
system. Results of the robotic abdominal
phase are awaited in the near future.
Conclusion
In conclusion, robotic-assisted mini-
mally invasive esophagectomywith
two-field lymphadenectomy is an ex-
cellent minimally invasive technique for
dissecting the esophagus from theme-
diastinumwith radical lymphadenec-
tomy. Additionally, it may provide new
curative options in patients deemed
inoperable with conventional surgery.
Robotic assistance reduces the limita-
tions of MIE while retaining its advan-
tages over open esophagectomy. There-
fore, we initiated a randomized con-
trolled trial, comparing robot-assisted
and open three-phase esophagec-
tomy tomeasure the additional value
of RAMIE over open esophagectomy
[29]. Short-term results are expected in
the course of 2016.
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